Analgesia for total knee arthroplasty:comparing single shot adductor canal block with dexmedetomidine as an adjuvant and continuous femoral nerve block

Analgesia for total knee arthroplasty:comparing single shot adductor canal block with dexmedetomidine as an adjuvant and continuous femoral nerve block - anealgesia for TKA: single shot adductor canal block with dexmedetomidine vs continuous femoral nerve block.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036466

Enrollment

Registered

2019-04-10

Start date

2017-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total knee arthroplasty

Interventions

single shot adductor canal block with 0.75%ropivacaine 15ml+ dexmedetomidine 50mcg Sciatic nerve block with 0.375% ropivacaine 10ml single shot femoral nerve block with 0.75% ropivacaine 15ml Sciati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient undergoing unilateral total knee arthroplasty patient with ASA-PS I-III

Exclusion criteria

Exclusion criteria: patient undergoing Bilateral TKA patient undergoing revision TKA patient allergic to local anesthetics patient we consider ineligible

Design outcomes

Primary

Measure	Time frame
rehabilitation progress(time to achieve knee flexion 120 degree)	—

Secondary

Measure	Time frame
rehabilitation progress (time to achieve knee flexion 90 degree, time to start moving to wheel chair and ambulatory, time to stable ambulatory) Visual analog scale postoperative additional analgesics satisfaction questionnaire complication	—

Countries

Japan

Contacts

Public ContactTAKEHIKO NAGAOKA

Shin-Yurigaoka General Hospital department of anesthesiology

takeitezzz@gmail.com0443229991

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026